Abstract
Hypertension is an independent determinant of cardiovascular risk, a phenotype that usually has a strong genetic component. Neuropeptide Y (NPY) plays an important role in BP homeostasis. The aim of this study was to investigate the possible influence of NPY polymorphisms on hypertension in a South Indian population. A total of 252 subjects (132 controls and 120 hypertensives) were analysed for T1128C, G1258A and A7735G polymorphisms in the NPY gene. Body mass index (BMI), pulse, SBP and DBP were assessed. Direct sequencing of PCR products was adopted for genotyping. All three polymorphisms were found to be in Hardy–Weinberg equilibrium. Additive, dominant and recessive models were tested using multivariate regression analysis. The results of our study reveal a significant association between T1128C and hypertension even after adjusting for age, sex and BMI. The adjusted OR (95% confidence interval) for the recessive model was 0.56 (0.33–0.95). The other two polymorphic sites (G1258A and A7735G) are not associated with hypertension. The Pro7 allele of the T1128C polymorphic site-containing haplotype (CGA) is associated with hypertension (P=0.049), but the combined haplotypes did not show any evidence of haplotype–phenotype association (global P=0.129). These data support the hypothesis that hypertension is influenced by the NPY T1128C polymorphism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reddy KS . Hypertension control in developing countries: generic issues. J Hum Hypertens 1996; 10 (Suppl 1): S33–S38.
Hypertension study group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study. Bull World Health Organ 2001; 79 (6): 490–500.
Smith C . Blood pressures of Sherpa men in modernizing Nepal. Am J Hum Biol 1999; 11 (4): 469–479.
Bevan JA, Brayden JE . Nonadrenergic neural vasodilator mechanisms. Circ Res 1987; 60 (3): 309–326.
Tatemoto K, Carlquist M, Mutt V . Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296 (5858): 659–660.
Gray TS, Morley JE . Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci 1986; 38 (5): 389–401.
O′Shea D, Morgan DG, Meeran K, Edwards CM, Turton MD, Choi SJ et al. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 1997; 138 (1): 196–202.
Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116 (4): 477–480.
Malmstrom RE . Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. Acta Physiol Scand Suppl 1997; 636: 1–55.
Corr L, Burnstock G, Poole-Wilson P . Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine. Peptides 1993; 14 (2): 359–364.
Ullman B, Franco-Cereceda A, Hulting J, Lundberg JM, Sollevi A . Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man. J Intern Med 1990; 228 (6): 583–589.
Minth CD, Andrews PC, Dixon JE . Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J Biol Chem 1986; 261 (26): 11974–11979.
Baker E, Hort YJ, Ball H, Sutherland GR, Shine J, Herzog H . Assignment of the human neuropeptide Y gene to chromosome 7p15.1 by nonisotopic in situ hybridization. Genomics 1995; 26 (1): 163–164.
Minth CD, Bloom SR, Polak JM, Dixon JE . Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 1984; 81 (14): 4577–4581.
Karvonen MK, Valkonen VP, Lakka TA, Salonen R, Koulu M, Pesonen U et al. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis 2001; 159 (1): 145–151.
Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab 2000; 85 (6): 2266–2269.
Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A et al. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 1998; 4 (12): 1434–1437.
Pickering TG . Blood pressure monitoring outside the office for the evaluation of patients with resistant hypertension. Hypertension 1988; 11 (3 Pt 2): II96–I100.
World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-Committee. Blood Press Suppl 1999; 1: 9–43.
Thangaraj K, Joshi MB, Reddy AG, Gupta NJ, Chakravarty B, Singh L . CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J Androl 2002; 23 (6): 815–818.
Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F et al. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 1997; 74 (4): 374–379.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 (2): 263–265.
Tzeng JY, Wang CH, Kao JT, Hsiao CK . Regression-based association analysis with clustered haplotypes through use of genotypes. Am J Hum Genet 2006; 78 (2): 231–242.
Niskanen L, Voutilainen-Kaunisto R, Terasvirta M, Karvonen MK, Valve R, Pesonen U et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with retinopathy in type 2 diabetes. Exp Clin Endocrinol Diabetes 2000; 108 (3): 235–236.
Erkkila AT, Lindi V, Lehto S, Laakso M, Uusitupa MI . Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Mol Genet Metab 2002; 75 (3): 260–264.
Wallerstedt SM, Skrtic S, Eriksson AL, Ohlsson C, Hedner T . Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population. J Hypertens 2004; 22 (7): 1277–1281.
Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347 (24): 1916–1923.
Drube J, Kawamura N, Nakamura A, Ando T, Komaki G, Inada T . No leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y in Japanese population or Japanese with alcoholism. Psychiatr Genet 2001; 11 (1): 53–55.
Makino K, Kataoka Y, Hirakawa Y, Ikeda A, Yamauchi A, Oishi AR . A leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y was not identified in the Japanese population. J Clin Pharm Ther 2001; 26 (3): 201–203.
Ding B, Bertilsson L, Wahlestedt C . The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population. J Clin Pharm Ther 2002; 27 (3): 211–212.
Jia C, Liu Z, Liu T, Ning Y . The T1128C polymorphism of neuropeptide Y gene in a Chinese population. Arch Med Res 2005; 36 (2): 175–177.
Duan S, Gao R, Xing Q, Du J, Liu Z, Chen Q et al. A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci Lett 2005; 379 (1): 32–36.
Bhaskar LV, Thangaraj K, Shah AM, Pardhasaradhi G, Praveen Kumar K, Reddy AG et al. Allelic variation in the NPY gene in 14 Indian populations. J Hum Genet 2007; 52 (7): 592–598.
Pesonen U . NPY L7P polymorphism and metabolic diseases. Regul Pept 2008; 149 (1–3): 51–55.
Mitchell GC, Wang Q, Ramamoorthy P, Whim MD . A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J Neurosci 2008; 28 (53): 14428–14434.
Komaru T, Ashikawa K, Kanatsuka H, Sekiguchi N, Suzuki T, Takishima T . Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart. Circ Res 1990; 67 (5): 1142–1151.
Solt VB, Brown MR, Kennedy B, Kolterman OG, Ziegler MG . Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am J Hypertens 1990; 3 (11): 823–828.
Michalkiewicz M, Michalkiewicz T, Kreulen DL, McDougall SJ . Increased blood pressure responses in neuropeptide Y transgenic rats. Am J Physiol Regul Integr Comp Physiol 2001; 281 (2): R417–R426.
Acknowledgements
This work was supported by a grant from Department of Biotechnology, Government of India (grant no. BT/PR3607/SPD/09/261/2003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bhaskar, L., Thangaraj, K., Non, A. et al. Neuropeptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population. J Hum Hypertens 24, 617–622 (2010). https://doi.org/10.1038/jhh.2009.104
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2009.104
Keywords
This article is cited by
-
Association of neuropeptide Y promoter polymorphism (rs16147) with perceived stress and cardiac vagal outflow in humans
Scientific Reports (2016)
-
Polymorphisms in LEP and NPY genes modify the response to soluble fibre Plantago ovata husk intake on cardiovascular risk biomarkers
Genes & Nutrition (2013)